DIGIANDOMENICO ANTHONY — SEC Form 4 filings
SEC reporting owner CIK 1083544. 23 Form 4 filings on record with FilingPulse; latest filed 2026-07-02.
Transaction summary — filings shown
Covers all 23 filings on record, filed 2024-02-23 to 2026-07-02. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): 28 legs across 14 filings — 21,438 shares, $129,080 total (shares × price as filed).
- Open-market sales (code S, non-derivative): none reported.
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 13.
- Largest priced transaction: purchase of 1,693 shares @ $6.21 ($10,514) in MDB Capital Holdings, LLC, filed 2024-12-20.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| MDB Capital Holdings, LLC (MDBH) | Director, 10% owner | 17 | 28 legs · 21,438 sh · $129,080 | — | 6 |
| ENDRA Life Sciences Inc. (NDRA) | Director | 4 | — | — | 5 |
| ClearSign Technologies Corp (CLIR) | Director | 2 | — | — | 2 |
Form 4 filings — DIGIANDOMENICO ANTHONY
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-07-02 | 4 | ClearSign Technologies Corp (CLIR) | Grant/award (A): 4,595 (derivative) @ $0 | EDGAR |
| 2026-04-02 | 4 | ClearSign Technologies Corp (CLIR) | Grant/award (A): 3,024 (derivative) @ $0 | EDGAR |
| 2026-01-23 | 4 | ENDRA Life Sciences Inc. (NDRA) | Grant/award (A): 60,324 @ $0 | EDGAR |
| 2025-10-15 | 4 | ENDRA Life Sciences Inc. (NDRA) | Grant/award (A): 70,822 @ $7.06 · Grant/award (A): 141,644 (derivative) @ $7.06 | EDGAR |
| 2025-08-08 | 4/A | MDB Capital Holdings, LLC (MDBH) | Purchase (P): 1,425 @ $4.90 | EDGAR |
| 2025-08-08 | 4/A | MDB Capital Holdings, LLC (MDBH) | Disposition to issuer (D): 900,000 (derivative) @ $0 · Grant/award (A): 900,000 (derivative) @ $0 | EDGAR |
| 2025-07-01 | 4 | ENDRA Life Sciences Inc. (NDRA) | Grant/award (A): 5,384 @ $0 | EDGAR |
| 2025-04-29 | 4 | MDB Capital Holdings, LLC (MDBH) | Disposition to issuer (D): 900,000 (derivative) @ $0 · Grant/award (A): 900,000 (derivative) @ $0 | EDGAR |
| 2025-04-09 | 4 | MDB Capital Holdings, LLC | Purchase (P): 1,425 @ $4.90 | EDGAR |
| 2025-02-14 | 4 | MDB Capital Holdings, LLC (MDBH) | Purchase (P): 290 @ $6.15 · Purchase (P): 942 @ $6.15 | EDGAR |
| 2025-02-11 | 4 | MDB Capital Holdings, LLC (MDBH) | Purchase (P): 1,000 @ $6.22 · Purchase (P): 1,000 @ $6.22 | EDGAR |
| 2025-02-06 | 4 | MDB Capital Holdings, LLC (MDBH) | Purchase (P): 398 @ $6.22 · Purchase (P): 300 @ $6.24 | EDGAR |
| 2025-02-03 | 4 | MDB Capital Holdings, LLC (MDBH) | Purchase (P): 100 @ $6.22 · Purchase (P): 1,000 @ $6.20 · Purchase (P): 1,000 @ $6.17 | EDGAR |
| 2025-01-29 | 4 | MDB Capital Holdings, LLC (MDBH) | Purchase (P): 933 @ $6.21 · Purchase (P): 14 @ $6.21 | EDGAR |
| 2025-01-27 | 4 | MDB Capital Holdings, LLC (MDBH) | Purchase (P): 928 @ $6.21 · Purchase (P): 200 @ $6.24 · Purchase (P): 164 @ $6.21 | EDGAR |
| 2025-01-21 | 4 | MDB Capital Holdings, LLC (MDBH) | Purchase (P): 900 @ $6.23 · Purchase (P): 1,000 @ $6.10 · Purchase (P): 1,000 @ $6.21 | EDGAR |
| 2025-01-15 | 4 | MDB Capital Holdings, LLC (MDBH) | Purchase (P): 1,000 @ $6.23 · Purchase (P): 1,000 @ $6.17 · Purchase (P): 1,000 @ $6.04 | EDGAR |
| 2025-01-07 | 4 | MDB Capital Holdings, LLC (MDBH) | Purchase (P): 16 @ $6.25 | EDGAR |
| 2024-12-30 | 4/A | MDB Capital Holdings, LLC (MDBH) | Purchase (P): 355 @ $6.25 | EDGAR |
| 2024-12-23 | 4 | MDB Capital Holdings, LLC (MDBH) | Purchase (P): 355 @ $6.25 | EDGAR |
| 2024-12-20 | 4 | MDB Capital Holdings, LLC (MDBH) | Option exercise (M): 50,000 @ $6.81 · Option exercise (M): 50,000 (derivative) @ $0 | EDGAR |
| 2024-12-20 | 4 | MDB Capital Holdings, LLC (MDBH) | Purchase (P): 1,693 @ $6.21 · Purchase (P): 1,000 @ $6.20 · Purchase (P): 1,000 @ $6.24 | EDGAR |
| 2024-02-23 | 4 | ENDRA Life Sciences Inc. (NDRA) | Grant/award (A): 600 (derivative) @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1083544 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →